Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.

<h4>Introduction</h4>People with dementia experience complex healthcare needs. Clinical pharmacists play a crucial role in optimising medication management and ensuring patient safety within the primary care setting. However, little is known about the specific barriers and challenges the...

Full description

Saved in:
Bibliographic Details
Main Authors: Alice Burnand, Kumud Kantilal, Abi Woodward, Cini Bhanu, Jill Manthorpe, Mine Orlu, Greta Rait, Kritika Samsi, Liz Sampson, Victoria Vickerstaff, Jane Wilcock, Yogini Jani, Nathan Davies
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0325472
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849471682032435200
author Alice Burnand
Kumud Kantilal
Abi Woodward
Cini Bhanu
Jill Manthorpe
Mine Orlu
Greta Rait
Kritika Samsi
Liz Sampson
Victoria Vickerstaff
Jane Wilcock
Yogini Jani
Nathan Davies
author_facet Alice Burnand
Kumud Kantilal
Abi Woodward
Cini Bhanu
Jill Manthorpe
Mine Orlu
Greta Rait
Kritika Samsi
Liz Sampson
Victoria Vickerstaff
Jane Wilcock
Yogini Jani
Nathan Davies
author_sort Alice Burnand
collection DOAJ
description <h4>Introduction</h4>People with dementia experience complex healthcare needs. Clinical pharmacists play a crucial role in optimising medication management and ensuring patient safety within the primary care setting. However, little is known about the specific barriers and challenges they face when delivering dementia care. This study investigates the safety of dementia care in the community, focusing on the experiences of clinical pharmacists.<h4>Methods</h4>A qualitative study using semi-structured interviews with clinical pharmacists. Data analysis employed codebook thematic analysis, guided by the SEIPS 2.0 framework.<h4>Results</h4>Thirteen clinical pharmacists were interviewed. Key risks include variations in pharmacist expertise, communication barriers, limited resources, and systemic challenges. Using the SEIPS 2.0 framework, the complex interactions between work systems (people, tools, tasks, organisation and environment) and work processes were identified, which impact safety outcomes for both clinical pharmacists and people with dementia.<h4>Conclusions</h4>Interviews revealed a spectrum of risks associated with dementia care in primary care. This study highlights the complex interplay of factors influencing the safety of dementia care. A proactive, multifaceted approach addressing training, interprofessional collaboration, and system-level adaptations is crucial to mitigate these risks and enhance patient safety in dementia care.
format Article
id doaj-art-2458fa6f78ad436895b9e22a70ca68fe
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-2458fa6f78ad436895b9e22a70ca68fe2025-08-20T03:24:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01206e032547210.1371/journal.pone.0325472Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.Alice BurnandKumud KantilalAbi WoodwardCini BhanuJill ManthorpeMine OrluGreta RaitKritika SamsiLiz SampsonVictoria VickerstaffJane WilcockYogini JaniNathan Davies<h4>Introduction</h4>People with dementia experience complex healthcare needs. Clinical pharmacists play a crucial role in optimising medication management and ensuring patient safety within the primary care setting. However, little is known about the specific barriers and challenges they face when delivering dementia care. This study investigates the safety of dementia care in the community, focusing on the experiences of clinical pharmacists.<h4>Methods</h4>A qualitative study using semi-structured interviews with clinical pharmacists. Data analysis employed codebook thematic analysis, guided by the SEIPS 2.0 framework.<h4>Results</h4>Thirteen clinical pharmacists were interviewed. Key risks include variations in pharmacist expertise, communication barriers, limited resources, and systemic challenges. Using the SEIPS 2.0 framework, the complex interactions between work systems (people, tools, tasks, organisation and environment) and work processes were identified, which impact safety outcomes for both clinical pharmacists and people with dementia.<h4>Conclusions</h4>Interviews revealed a spectrum of risks associated with dementia care in primary care. This study highlights the complex interplay of factors influencing the safety of dementia care. A proactive, multifaceted approach addressing training, interprofessional collaboration, and system-level adaptations is crucial to mitigate these risks and enhance patient safety in dementia care.https://doi.org/10.1371/journal.pone.0325472
spellingShingle Alice Burnand
Kumud Kantilal
Abi Woodward
Cini Bhanu
Jill Manthorpe
Mine Orlu
Greta Rait
Kritika Samsi
Liz Sampson
Victoria Vickerstaff
Jane Wilcock
Yogini Jani
Nathan Davies
Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.
PLoS ONE
title Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.
title_full Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.
title_fullStr Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.
title_full_unstemmed Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.
title_short Identifying risks in dementia care: Insights from a qualitative study with clinical pharmacists.
title_sort identifying risks in dementia care insights from a qualitative study with clinical pharmacists
url https://doi.org/10.1371/journal.pone.0325472
work_keys_str_mv AT aliceburnand identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT kumudkantilal identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT abiwoodward identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT cinibhanu identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT jillmanthorpe identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT mineorlu identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT gretarait identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT kritikasamsi identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT lizsampson identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT victoriavickerstaff identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT janewilcock identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT yoginijani identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists
AT nathandavies identifyingrisksindementiacareinsightsfromaqualitativestudywithclinicalpharmacists